ST Elevation Acute Myocardial Infarction
7
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
1 terminated out of 7 trials
83.3%
-3.2% vs benchmark
57%
4 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of Myocardial Salvage in Gated SPECT Early After Acute Myocardial Infarction
Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study
Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction
RadIal Versus Femoral InvEstigation in ST Elevation Acute Coronary Syndrome
ThromboAblation in Acute Myocardial Infarction